tiprankstipranks
Dyne Therapeutics presents new data from Phase 1/2 ACHIEVE trial of DYNE-101
PremiumThe FlyDyne Therapeutics presents new data from Phase 1/2 ACHIEVE trial of DYNE-101
1M ago
Dyne Therapeutics initiated with an Outperform at Baird
Premium
The Fly
Dyne Therapeutics initiated with an Outperform at Baird
2M ago
Dyne Therapeutics initiated with an Outperform at RBC Capital
Premium
The Fly
Dyne Therapeutics initiated with an Outperform at RBC Capital
3M ago
Dyne Therapeutics presents data highlighting FORCE platform
PremiumThe FlyDyne Therapeutics presents data highlighting FORCE platform
5M ago
Dyne Therapeutics management to meet with Piper Sandler
Premium
The Fly
Dyne Therapeutics management to meet with Piper Sandler
5M ago
Piper says buy Dyne ahead of ACHIEVE/DELIVER data, registrational cohorts
Premium
The Fly
Piper says buy Dyne ahead of ACHIEVE/DELIVER data, registrational cohorts
5M ago
Morning Movers: U.S. Steel drops after VP Harris opposes sale to Nippon
PremiumThe FlyMorning Movers: U.S. Steel drops after VP Harris opposes sale to Nippon
6M ago
Dyne Therapeutics: Executive Shifts and Promising Clinical Trials
Premium
Company Announcements
Dyne Therapeutics: Executive Shifts and Promising Clinical Trials
6M ago
Dyne Therapeutics’ DYNE-251 in DMD shows efficacy in Phase 1/2 trial
Premium
The Fly
Dyne Therapeutics’ DYNE-251 in DMD shows efficacy in Phase 1/2 trial
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100